HIV Clinical Forum
Meeting category
Date(s)
31 Oct 2020
Organizer

中国 HIV 临床论坛 2020

Related Enduring Materials

大会日程

北京时间10月31日星期六

CST=北京时间

- 13:00
13:00 CST
开幕式
大会报告一:整合酶抑制剂INSTIs在临床中的最佳使用 - 13:05
13:05 CST
中国艾滋病的诊疗进程和研究挑战
Taisheng Li, MD, PhD
Peking Union Medical College Hospital, China
13:25 CST
对耐药性的考虑,当选择下一个疗法
Kiat Ruxrungtham, MD
Chulalongkorn University, Thailand
13:45 CST
近二十年来中国艾滋病毒耐药性趋势
Lulu Zuo
Lulu Zuo
Institut Pasteur of Shanghai, Chinese Academy of Sciences
14:00 CST
迈向双重疗法
Lin, Hsi-Hsun
Hsi-Hsun Lin, MD, PhD
Taipei Veterans General Hospital
14:20 CST
问答
大会报告二:特殊人群的抗逆转录病毒治疗(ARV) - 14:45
14:45 CST
抗逆转录病毒药物ARVs在老年人群中的选择考虑
Giovanni Guaraldi, MD
University of Modena and Reggio Emilia, Italy
15:05 CST
抗逆转录病毒药物ARVs在女性中的选择考虑
Reshmie Ramautarsing
Reshmie Ramautarsing, MD, PhD
Thai Red Cross AIDS Research Centre
15:25 CST
育龄期艾滋病女性的抗病毒治疗案例展示
Lijun Sun, PhD
Beijing You'an Hospital, Capital Medical University, China
15:40 CST
问答
论坛报告三:艾滋病毒和非艾滋病相关合并症/合并感染 - 16:10
16:10 CST
HIV-肝炎合并感染患者
Jürgen Rockstroh, MD
University of Bonn, Germany
16:30 CST
HIV与骨矿物质密度
Evelyn Hsieh
Evelyn Hsieh, MD, PhD
Yale School of Medicine
16:50 CST
HIV与机会性感染
Christine Katlama
Christina Katlama, MD
Hôpital Pitié-Salpêtrière, France
17:10 CST
问答
会议报告四:预防策略 - 17:35
17:35 CST
HIV预防措施;实施暴露前预防(PrEP)
Jean-Michel Molina, MD, PhD
Saint-Louis/Lariboisière Hospitals and University of Paris, France
17:55 CST
讨论
18:25 CST
结束语
会议概况
欢迎

会议更新

2020年中国HIV临床论坛:优化治疗将会在北京时间10月31日星期六下午1:00 - 6:30以网络会议的形式举行。在会议期间,参会人员可登录会议线上平台观看全程会议和参与讨论。

​若您对于参会此次会议有任何疑问,欢迎随时来邮询问,联系人袁女士weixi@amededu.com.

了解更多有关会议的更新,请订阅我们的电子快报​。

关于会议

本次会议将提供最新的,最具挑战话题的大会报告,同时留有足够的问答的时间,以此来促进专家组们和中国艾滋病治疗社区间的互动,同时弥补和缩减知识差距。本次大会还会对临床案例中出现的现实问题和挑战进行报告讨论。参会者将借此次宝贵的机会与国内外各专家进行深入交流学习!大会将提供中英双语同传服务。

HIV临床论坛系列

针对有关艾滋病新兴课题而开展的独立医学教育项目是个分布在全世界的系列互动课程,艾滋病毒临床论坛是其中的一个会议课程。该会议课程以国际和当地专家为特色,为艾滋病临床医师和专职医疗人员提供有关艾滋病管理的最新进展信息,为分享临床经验和展示正在进行和已经完成的研究计划提供平台。

​组委会
当地主席

会议相关信息

Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients

- Create a platform for interactive information exchange on novel treatment options

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies

- Describe the pros and cons of novel treatment strategies

- Understand how to integrate novel treatment strategies into routine patient care

- Be knowledgeable of the clinical data supporting long-acting injectable regimens

- Identify patients who might best benefit from long acting injectable regimens

- Know how best to integrate injectable drugs in to routine clinical care

- Improve their skills in defining and identifying complex HIV patients

- Stay informed on new drug options for complex patients

- Understand how best to use new treatment options in complex HIV patients
其余信息

我们希望以下信息可以帮助您更好的进行大会注册。

Certificate of Attendance
A certificate of attendance was sent by e-mail to participants.
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Languages
The official language of this meeting was Chinese.
​组委会

The Program Chairs are experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.

​组委会
当地主席
大会支持

The Chinese HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.​

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.